Research
Funding Process Reaches Next Steps for Spinal Muscular Atrophy Clinical Care Research
At the end of last week, we announced the close of our for request for proposals (RFP) for clinical care research. A clinical care RFP […]
Read More ›Cure SMA Featured in Assay and Drug Development Technologies
Cure SMA was featured in the July/August issue of Assay and Drug Development Technologies, a scientific journal that focuses on the development of new drugs. […]
Read More ›Spinal Muscular Atrophy Mice Model Results Published in the Journal Science
On August 7, the journal Science published results of a preclinical study demonstrating that treatment with orally available RNA splicing modifiers of the SMN2 gene […]
Read More ›Isis Begins Phase III Clinical Trial
On August 1, Isis Pharmaceuticals, Inc. announced today the initiation of a pivotal Phase III study evaluating ISIS-SMNRx in infants with spinal muscular atrophy (SMA). […]
Read More ›Cure SMA Announces New Research Funding
Cure SMA is proud to announce that we will be committing $1.8 million to new research funding over the next 12 months. Fifteen years ago, […]
Read More ›- « Previous
- 1
- …
- 38
- 39
- 40